facebook

CanniMed says hostile takeover bid by Aurora weighing on share value

CanniMed Therapeutics Inc. is urging its shareholders to reject a hostile takeover bid by competitor Aurora Cannabis Inc., admonishing the value of the proposed deal and its effect on its share price.

In a letter to shareholders released Wednesday, the Saskatoon-based medical marijuana producer said its shares are trading above Aurora’s offer of $24 and would likely be higher if it were not for the all-stock hostile bid.


READ MORE:
Aurora Cannabis purchases 116K common shares of CanniMed Therapeutics

CanniMed said the Edmonton-based company is offering shares that were worth only half as much just two weeks before its hostile bid was announced last fall and that it is inferior to its own proposed acquisition of Tragically Hip-backed Newstrike Resources Ltd. (TSXV:HIP).

“The combination of CanniMed and Newstrike creates a major player across the Canadian recreational and global medical markets and will be valued as such,” CanniMed said in the letter to shareholders.

“We see a clear path to $37 per CanniMed share – or more.”

Aurora formally launched its hostile takeover bid for CanniMed in late November on the condition that CanniMed cancel its own planned acquisition and said its offer will remain on the table until March 9.

Cam Battley, executive vice-president of Aurora, said in an emailed statement that he took issue with what he called “misleading” information attributed to him in the shareholder letter that he said was taken out of context.

He later said in a telephone interview that CanniMed’s letter “just reeks of desperation.”

Stock commentary website Citron Research said Wednesday that Aurora is “the weakest player in the space,” arguing that the company’s hostile bid for CanniMed shows that the company irresponsibly allocates capital. Citron said Aurora “is spending $600 million on the deal when the barriers to entry are deteriorating.”

Citron also said Aurora’s stock should retrace 50 per cent, setting its short-term share target at $6.50.


READ MORE:
OSC cease-trades CanniMed rights plan, orders Aurora to amend disclosures

Battley said Aurora’s acquisitions have “benefited both our shareholders and their companies,” pointing to its investments in Radient Technologies Inc. (TSXV:RTI), Hempco Food and Fiber (TSXV:HEMP) and Cann Group in Australia.

“Our strategic investments with our partners have increased in value from $40 million to $180 million, or about a 350 per cent growth since we made those investments,” he said.

The acrimonious takeover battle between the two marijuana companies was in the regulatory spotlight last month at a joint hearing involving the Saskatchewan and Ontario securities commissions.

The Ontario Securities Commission ruled on Dec. 22 that any securities issued by CanniMed as a defence against a hostile takeover by Aurora will be cease-traded. Aurora, for its part, will be required to amend its takeover bid circular and related press releases to include certain information that could affect CanniMed’s shareholders when they decide to accept or reject an offer.

Shares of CanniMed (TSX:CMED) closed 7.25 per cent higher, at $26.13, while Aurora (TSX:ACB) closed up 20.3 per cent, at $14.18 at the end of trading Wednesday.



Source link


Global News Feed

Global News Feed

GlobalNews.ca offers Canadians from coast to coast a host of news and information – from breaking news in their town or city to deep engaging content that puts complex world issues in perspective. Our 11 local sites provide up-to-the-minute community-based news, weather and information, while our new umbrella national site features stories, analysis and deep, engaging content about issues in Canada and abroad.
Buds2Go.ca is not responsible for, nor do we always share the opinions of the content posted on our website through our partners or independent authors.

Leave a Reply


What is a Sativa?

Sativa strains of medicinal marijuana are usually uplifting and stimulating. If you’ve ever smoked or ingested cannabis that makes everything funny and puts you in a great mood, it was probably from a Sativa strain. It creates a feeling of comfort, non-drowsy, and usually introspective highs. The effects of smoking or ingesting a Sativa makes them particularly popular among artists and creatives. The most popular medicinal benefits range from treating mental and behavioral problems, to treating depression, stress and ADHD.

What is an Indica?

The major difference between Sativa’s and Indica’s is while a Sativa can make you feel alert, active, and aware, an Indica will have a relaxing feel on the body. The physical effects of an Indica strain commonly include a drowsy and mellow mood with stress and pain relief. Indica’s are one of the more suggested strains when using it for medicinal purposes as it effectively treats sleeping disorders such as insomnia, fibromyalgia, body aches and pains. Indica’s are also commonly used for treating Multiple Sclerosis, Parkinson’s disease, Fibromyalgia and Lupus

Why Choose Hybrid?

The benefits to smoking or ingesting a Hybrid strain are simply as follows. Hybrid’s offer the best of both worlds combining several qualities of each containing strain. Some Hybrid’s are Indica dominant, which will offer pain relief and / or mellow mood, however may contain up to 50% Sativa so it will not make you too drowsy. Other’s may offer a Sativa dominant strain, which will encompass several calming benefits and pain relief, but also give a mellow, yet energetic high.

Why use Buds2Go?

We offer a guaranteed, reliable medicinal marijuana buying and shipping experience for our members. There are still thousands of people who don’t live in areas that are served by local dispensaries such as Vancouver and Victoria BC. We offer mail order marijuana in canada that is both fast and discreet and always include tracking numbers. Mail Order Medical Marijuana - Medicinal Cannabis Dispensary - Buy Weed Online